Sumitomo Pharma Co., Ltd.
SMDPY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $29 | $143 | $203 |
| Short-Term Investments | $17 | $7 | $20 | $36 |
| Receivables | $75 | $81 | $96 | $151 |
| Inventory | $94 | $115 | $94 | $99 |
| Other Curr. Assets | $44 | $37 | $28 | $11 |
| Total Curr. Assets | $253 | $270 | $382 | $500 |
| Property Plant & Equip (Net) | $47 | $58 | $59 | $64 |
| Goodwill | $197 | $200 | $209 | $195 |
| Intangibles | $173 | $196 | $329 | $399 |
| Long-Term Investments | $72 | $162 | $144 | $128 |
| Tax Assets | $1 | $0 | $11 | $23 |
| Other NC Assets | $0 | $23 | $0 | $0 |
| Total NC Assets | $489 | $638 | $753 | $808 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $743 | $908 | $1,135 | $1,308 |
| Liabilities | – | – | – | – |
| Payables | $39 | $39 | $13 | $22 |
| Short-Term Debt | $46 | $286 | $91 | $25 |
| Tax Payable | $2 | $1 | $24 | $8 |
| Deferred Revenue | $0 | $0 | $152 | $140 |
| Other Curr. Liab. | $154 | $158 | $240 | $202 |
| Total Curr. Liab. | $241 | $515 | $373 | $278 |
| LT Debt | $259 | $133 | $244 | $244 |
| Deferred Rev, NC | $0 | $0 | $17 | $28 |
| Deferred Tax Liab, NC | $27 | $38 | $37 | $27 |
| Other NC Liab. | $47 | $59 | $51 | $48 |
| Total NC Liab. | $333 | $236 | $355 | $356 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $5 | $7 | $10 |
| Total Liabilities | $573 | $751 | $728 | $634 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $22 | $22 | $22 | $22 |
| Retained Earnings | $47 | -$23 | $281 | $514 |
| AOCI | $101 | $157 | $104 | $55 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $169 | $156 | $407 | $608 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $66 |
| Total Liab. & Tot. Equity | $743 | $908 | $1,135 | $1,308 |
| Net Debt | $282 | $390 | $191 | $66 |